ArticleJournal of health economics and outcomes research2022

Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis.

Ci Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.